23andMe in the Medical Space
I like 23andMe. I like to have unfettered access to all information —including my genomics —even if that means “bending” the rules. However, while the medical intentions of 23andMe were ambiguous before, BRCA and pharmacogenomic testing for statins are unambiguously medical tests. Unlike other genomic testing companies who misrepresented themselves as endorsed by the medical community — 23andMe pretended no such endorsement. I liked that. I like honest rule breakers when the rules are wrong.
But now…
I sure as hell hope that the people at 23andMe know something that I don’t, because this looks to me like an excuse to call down the federal ban hammer, and what a shame that would be simply because a few people in Mountain View didn’t bother to file some paperwork. Surely, 23andMe has access to the political will, talent, and funding to secure any licenses if they chose to, so this is a deliberate attempt to push the rules.
Well, I’m going to hold on my opinion, other than state that while I eagerly anticipate the application of genomic sequences in health care, I don’t know how 23andMe expects to be integrated into medicine when 23andMe’s terms of service clearly state that it is NOT to be integrated into medicine. I suppose some other company will eat that lunch? Who knows.



Think Gene at Technorati
Add New Comment
Viewing 7 Comments
Thanks. Your comment is awaiting approval by a moderator.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Do you already have an account? Log in and claim this comment.
Add New Comment
Trackbacks